MoonLake Immunotherapeutics, a clinical-stage biotech firm valued at $2.6 billion, is generating excitement with its ...

Pfizer named Dr Chris Boshoff as CSO and president of R&D, effective 1st January 2025. Boshoff, previously Pfizer’s chief ...

While the deals done this week are important for the future direction of the industry – US company Gilead (US:GILD) inked the biggest, paying up to $1.7bn for Leo Pharma’s range of pre-clinical ...

Rapid advancements in technology and heightened regulatory requirements are propelling growth in the pharma and biotech CRM ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.